KLOW

GLOW plus an anti-inflammatory arm. It calms inflammation so the repair peptides work in a cleaner setting.

Evidence: DCommunity use what's this?
Grade D for the combination. Components range from B (GHK-Cu topical) to E.
Also known as: GHK-Cu 50 mg + BPC-157 10 mg + TB-500 10 mg + KPV 10 mg (80 mg vial)
Class: Community four-peptide repair blend, 5:1:1:1. No trials of the blend itself.

The 30-second version

WhatThe three GLOW peptides plus KPV, which switches off the NF-κB inflammation switch.

Why people use itSkin, soft tissue and gut together, especially where inflammation is stalling recovery.

The honest catchFour peptides, no trials of the combination, and the same cancer caution as GLOW.

What it is

Chronic inflammation can blunt tissue repair. KLOW adds KPV (16) to the GLOW base of GHK-Cu (17), BPC-157 (08) and TB-500 (09), aiming to quiet that background noise. BPC-157 and KPV both support the intestinal lining, which makes KLOW a common choice when gut inflammation sits alongside skin or joint issues.

Four pathways at once

GHK-Cu: collagen, elastin and matrix remodelling.

BPC-157: local repair, new vessels, gut protection.

TB-500: repair-cell migration throughout the body.

KPV: blocks NF-κB; lowers IL-6, IL-8 and TNF-α in gut and skin.

Order: inflammation and soft tissue early, skin around weeks 3–4, gut across the cycle.

Evidence at a glance

Use	Grade	Best evidence	Main gap	Read
Skin and anti-ageing	DCommunity use	GHK-Cu (B) + KPV skin models (E)	Blend untested	Supportive
Gut inflammation	DCommunity use	BPC-157 + KPV gut mechanisms (E)	No human trials	Standout use
Soft-tissue recovery	DCommunity use	BPC-157 + TB-500 animal data	No human trials	Plausible

Dosing: what has been reported

Not a recommendation. These figures describe what was studied or what circulates in practice, kept separate so you can see how solid each one is. Speak with a qualified clinician before acting on any of it.

Setting	Figure	Route	Grade
Start	~2 mg total blend daily (10 units of a 20 mg/mL mix)	Subcutaneous	D
Working range	2.7–8 mg total daily, increased to response	Subcutaneous	D
Maintenance	~3 mg total daily; cycles of 8–12 weeks	Subcutaneous	D

The 80 mg vial is commonly mixed in 4 mL of bacteriostatic water (20 mg/mL). A 2 mg dose delivers about 1.25 mg GHK-Cu and 250 mcg each of BPC-157, TB-500 and KPV. The ratio is fixed, so use separate vials if you want to push one peptide.

Preparing & storing

Refrigerate once mixed, protect from light and don’t shake. Some suppliers advise colder storage for four-peptide blends, so follow the product guidance. A blue tint is normal.

Reported side effects

Injection-site reactions (most common)
Brief post-injection tiredness (TB-500)
Copper ceiling from GHK-Cu limits how high the dose can go
KPV adds very little risk; the profile is close to GLOW’s

Who should avoid it

Active or suspected cancer (BPC-157 and TB-500 are pro-angiogenic)
Pregnancy and breastfeeding; copper disorders
Autoimmune disease or immune-modulating drugs: get clinical input
Tested athletes: contains WADA-prohibited BPC-157 and TB-500

Regulatory status checked Oct 2026

Body	Status	Detail
BPC-157 / TB-500	Not approved	Both WADA prohibited.
GHK-Cu	Cosmetic ingredient	Not named by WADA.
KPV	Not approved	Not named by WADA.
KLOW blend	Not approved	Banned for tested athletes as a whole.

The NexGen read

The most complete repair blend on paper

KLOW adds real anti-inflammatory coverage to GLOW, which makes the most sense when the gut is involved. Like GLOW, the blend is used on community experience, so cycle it and screen for cancer risk first.

References

See component chapters: BPC-157 (08), TB-500 (09), KPV (16), GHK-Cu (17), and GLOW (19). No trials of the combination exist.